PepGen Inc.(PEPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PEPG PepGen Inc.

Pre-Mkt 07-16 07:11:49 EDT

2.40

-0.04

-1.64%

High2.57	Low2.22	Vol1.82M
Open2.42	D1 Closing2.44	Amplitude14.34%
Mkt Cap165.88M	Tradable Cap86.51M	Total Shares69.12M
T/O4.35M	T/O Rate5.06%	Tradable Shares36.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PEPG","market":"US","secType":"STK","nameCN":"PepGen Inc.","latestPrice":2.4,"timestamp":1784145600000,"preClose":2.44,"halted":0,"volume":1822772,"delay":0,"changeRate":-0.016393442622950834,"floatShares":36045800,"shares":69115292,"eps":-1.511087,"marketStatus":"Pre-Mkt","change":-0.04,"latestTime":"07-16 07:11:49 EDT","open":2.42,"high":2.57,"low":2.22,"amount":4345634.6343144,"amplitude":0.143443,"askPrice":2.39,"askSize":115,"bidPrice":2.29,"bidSize":1273,"shortable":3,"etf":0,"ttmEps":-1.511087,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784208600000},"marketStatusCode":1,"adr":0,"listingDate":1651809600000,"exchange":"NASDAQ","adjPreClose":2.4,"postHourTrading":{"tag":"盘后","latestPrice":2.36,"preClose":2.4,"latestTime":"18:45 EDT","volume":3590,"amount":8476.8273,"timestamp":1784155538784,"change":-0.04,"changeRate":-0.016667,"amplitude":0.016667},"volumeRatio":0.8842704651275544,"impliedVol":0.8742,"impliedVolPercentile":0.252},"requestUrl":"/m/hq/s/PEPG/tweets","defaultTab":"tweets","newsList":[{"id":"2645070343","title":"PepGen shareholders ratify KPMG as independent auditor for 2026 fiscal year","url":"https://stock-news.laohu8.com/highlight/detail?id=2645070343","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645070343?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:30","pubTimestamp":1782160259,"startTime":"0","endTime":"0","summary":"PepGen held its annual shareholder meeting on June 18, 2026.Shareholders selected three Class I directors for terms running to the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PepGen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLbPLhlr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645092919","title":"Analysts Are Bullish on These Healthcare Stocks: PepGen Inc. (PEPG), CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645092919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645092919?lang=en_us&edition=fundamental","pubTime":"2026-06-21 15:30","pubTimestamp":1782027005,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PepGen Inc. (PEPG) and CG Oncology, Inc. (CGON) with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-pepgen-inc-pepg-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-pepgen-inc-pepg-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643765808","title":"PepGen Initiated at Buy by Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2643765808","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643765808?lang=en_us&edition=fundamental","pubTime":"2026-06-16 22:44","pubTimestamp":1781621040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PEPG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2026 10:44 ET (14:44 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643675161","title":"Craig-Hallum Initiates PepGen at Buy With $11 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2643675161","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643675161?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:21","pubTimestamp":1781608879,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) has an average rating of buy and mean price target of $10.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639621318","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: PepGen Inc. (PEPG) and West Pharmaceutical Services (WST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2639621318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639621318?lang=en_us&edition=fundamental","pubTime":"2026-05-29 18:40","pubTimestamp":1780051243,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on PepGen Inc. (PEPG) and West Pharmaceutical Services (WST). PepGen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pepgen-inc-pepg-and-west-pharmaceutical-services-wst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pepgen-inc-pepg-and-west-pharmaceutical-services-wst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4504","IE00B64QTZ34.USD","IE00BFXG0V08.USD","BK4121","BK4137","LU0012050646.USD","HCSG","LU0106261612.USD","BK4588","WST","BK4585","PEPG","IE00BYQQ9H92.USD","BK4567","BK4581","LABU","LU0128526141.USD","XBI","LU0345774631.USD","LU0345774391.USD","XLV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637397211","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM), PepGen Inc. (PEPG) and Glaukos (GKOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637397211","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637397211?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:10","pubTimestamp":1779441059,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on HUTCHMED (HCM), PepGen Inc. (PEPG) and Glaukos (GK...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hutchmed-hcm-pepgen-inc-pepg-and-glaukos-gkos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hutchmed-hcm-pepgen-inc-pepg-and-glaukos-gkos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","PEPG","LU0029874061.USD","HCM","LU1878469433.USD","IE0009354923.USD","XBI","GKOS","XLV","BK4082","BK4137","LU0128526141.USD","BK4139","HCSG","BK4007","BK4548","BK4531","BK4585","BK4588","BK4581","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637938084","title":"PepGen presents FREEDOM-DM1 trial data for PGN-EDODM1 at IDMC-15","url":"https://stock-news.laohu8.com/highlight/detail?id=2637938084","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637938084?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:00","pubTimestamp":1779361242,"startTime":"0","endTime":"0","summary":"PepGen flagged new clinical data from its PGN-EDODM1 program for myotonic dystrophy type 1, with results set for presentation at the 15th International Myotonic Dystrophy Consortium meeting on May 26-30, 2026, in Quebec.The company plans to show analyses of individual patient mis-splicing, supported by natural history work intended to frame how mis-splicing changes in DM1.A separate poster is slated to highlight the FREEDOM-DM1 trial, describing strong splicing correction from single doses of PGN-EDODM1 with an acceptable safety profile.Additional single-dose data, alongside initial multiple ascending dose data, are scheduled for a May 26, 2026 Pharma Day presentation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PepGen Inc. publishe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL2GgzS6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636633798","title":"PepGen Files $400 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2636633798","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636633798?lang=en_us&edition=fundamental","pubTime":"2026-05-20 00:23","pubTimestamp":1779207808,"startTime":"0","endTime":"0","summary":"PepGen  filed a registration statement Monday for the potential sale of up to $400 million of securities from time to time.The filing covers common and preferred stocks, debt securities, warrants, and units.Net proceeds will be used for general corporate purposes, the company said.Price: 1.41, Change: -0.06, Percent Change: -4.08","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636872863","title":"PepGen files $400M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2636872863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636872863?lang=en_us&edition=fundamental","pubTime":"2026-05-20 00:10","pubTimestamp":1779207009,"startTime":"0","endTime":"0","summary":"12:08 EDT PepGen (PEPG) files $400M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-files-400m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-files-400m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636868496","title":"PepGen Inc - Files to Offer up to $400 Mln in Securities From Time to Time - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636868496","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636868496?lang=en_us&edition=fundamental","pubTime":"2026-05-20 00:04","pubTimestamp":1779206658,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W0MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636868495","title":"PepGen Inc - New Sales Agreement Replaces Prior Sales Agreement; Prior Agreement Terminated - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636868495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636868495?lang=en_us&edition=fundamental","pubTime":"2026-05-20 00:04","pubTimestamp":1779206658,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W0MC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636386849","title":"PepGen Inc - May Sell up to $100 Mln Common Stock Under Atm Agreement With Stifel - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2636386849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636386849?lang=en_us&edition=fundamental","pubTime":"2026-05-20 00:04","pubTimestamp":1779206658,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W0MC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635873601","title":"PepGen price target lowered to $4 from $5 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2635873601","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635873601?lang=en_us&edition=fundamental","pubTime":"2026-05-13 23:25","pubTimestamp":1778685932,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico lowered the firm’s price target on PepGen (PEPG) to $4 from $5 and keeps an Outperform rating on the shares. Most impor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pepgen-price-target-lowered-to-4-from-5-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pepgen-price-target-lowered-to-4-from-5-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635735160","title":"PepGen Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2635735160","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635735160?lang=en_us&edition=fundamental","pubTime":"2026-05-13 22:50","pubTimestamp":1778683800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PEPG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2026 10:50 ET (14:50 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635911780","title":"Wedbush Trims Price Target on PepGen to $4 From $5, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2635911780","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635911780?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:26","pubTimestamp":1778678790,"startTime":"0","endTime":"0","summary":"PepGen (PEPG) has an average rating of buy and mean price target of $10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and resea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635827887","title":"Wedbush Keeps Their Buy Rating on PepGen Inc. (PEPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635827887","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635827887?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:37","pubTimestamp":1778675853,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico maintained a Buy rating on PepGen Inc. today and set a price target of $4.00. According to TipRanks, Chico is a 5-star ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-pepgen-inc-pepg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wedbush-keeps-their-buy-rating-on-pepgen-inc-pepg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635372223","title":"PepGen Q1 EPS $(0.26) Beats $(0.31) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635372223","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635372223?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:06","pubTimestamp":1778619996,"startTime":"0","endTime":"0","summary":"PepGen (NASDAQ:PEPG) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 71.74 percent increase over losses of $(0.92) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52508906/pepgen-q1-eps-0-26-beats-0-31-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"PepGen Q1 EPS $(0.26) Beats $(0.31) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635240224","title":"PepGen Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635240224","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635240224?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:30","pubTimestamp":1778617846,"startTime":"0","endTime":"0","summary":"PepGen Inc reports results for the quarter ended March 31 - Earnings SummaryPepGen Inc PEPG.OQ reported a quarterly adjusted loss of 26 cents per share for the quarter ended March 31, higher than the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P331:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635778247","title":"PepGen Q1 loss narrows as operating expenses fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2635778247","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635778247?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:14","pubTimestamp":1778616862,"startTime":"0","endTime":"0","summary":"PepGen Q1 loss narrows as operating expenses fallOverviewUS biotechnology firm's Q1 net loss narrowed yr/yr as operating expenses declinedCompany ended Q1 with $132.3 mln in cash, seen funding operati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL1N41P1DH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247933","title":"PepGen Q1 FY26 net loss narrows to $17.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247933","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247933?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:06","pubTimestamp":1778616408,"startTime":"0","endTime":"0","summary":"PepGen posted a net loss of USD 17.8 million, or USD 0.26 per share, for quarter ended March 31, 2026, narrowing from a net loss of USD 30.2 million, or USD 0.92 per share, a year earlier.R&D expense fell to USD 13 million from USD 25.4 million, while G&A held flat at USD 5.9 million.Cash, cash equivalents and marketable securities slid to USD 132.3 million at March 31, 2026, from USD 148.5 million at Dec. 31, 2025; funding seen lasting into second half of 2027.FREEDOM2 10 mg/kg cohort for PGN-EDODM1 in DM1 is fully enrolled, with data expected in second half of 2026; 5 mg/kg cohort showed favorable safety, splicing and vHOT data.FDA placed a partial clinical hold tied to previously submitted preclinical pharmacology and toxicology studies, with timing of ongoing FREEDOM2 study unchanged.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL5b4cb2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pepgen.com","stockEarnings":[{"period":"1week","weight":0.206},{"period":"1month","weight":0.5686},{"period":"3month","weight":0.4371},{"period":"6month","weight":-0.5385},{"period":"1year","weight":0.9355},{"period":"ytd","weight":-0.6313}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0},{"period":"3month","weight":0.0757},{"period":"6month","weight":0.0913},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.057082},{"month":2,"riseRate":0.75,"avgChangeRate":0.580465},{"month":3,"riseRate":0,"avgChangeRate":-0.400307},{"month":4,"riseRate":0.5,"avgChangeRate":0.028304},{"month":5,"riseRate":0.25,"avgChangeRate":0.041771},{"month":6,"riseRate":0.2,"avgChangeRate":-0.115638},{"month":7,"riseRate":0.6,"avgChangeRate":0.01633},{"month":8,"riseRate":0.25,"avgChangeRate":-0.102699},{"month":9,"riseRate":0.25,"avgChangeRate":0.658187},{"month":10,"riseRate":0.75,"avgChangeRate":0.035806},{"month":11,"riseRate":0.5,"avgChangeRate":0.080021},{"month":12,"riseRate":0.5,"avgChangeRate":0.010709}],"exchange":"NASDAQ","name":"PepGen Inc.","nameEN":"PepGen Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PepGen Inc.(PEPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PepGen Inc.(PEPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PepGen Inc.,PEPG,PepGen Inc.股票,PepGen Inc.股票老虎,PepGen Inc.股票老虎国际,PepGen Inc.行情,PepGen Inc.股票行情,PepGen Inc.股价,PepGen Inc.股市,PepGen Inc.股票价格,PepGen Inc.股票交易,PepGen Inc.股票购买,PepGen Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PepGen Inc.(PEPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PepGen Inc.(PEPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction